---
title: "CHISON MEDICAL: Shareholders plan to collectively reduce their holdings in the company by no more than 1.72%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237702477.md"
description: "On the evening of April 27th, CHISON MEDICAL announced that its shareholders Wuxi Xiangding Investment Enterprise, Shanghai Yude Technology Co., Ltd., and Wuxi Xiangpeng Investment Enterprise plan to reduce their holdings in the company by a total of no more than 1.932 million shares, which is no more than 1.72% of the company's total share capital"
datetime: "2025-04-27T10:23:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237702477.md)
  - [en](https://longbridge.com/en/news/237702477.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237702477.md)
generator: "portal-rs"
---

# CHISON MEDICAL: Shareholders plan to collectively reduce their holdings in the company by no more than 1.72%

On the evening of April 27th, CHISON MEDICAL announced that its shareholders Wuxi Xiangding Investment Enterprise, Shanghai Yude Technology Co., Ltd., and Wuxi Xiangpeng Investment Enterprise plan to reduce their holdings in the company by a total of no more than 1.932 million shares, which is no more than 1.72% of the company's total share capital

### Related Stocks

- [688358.CN](https://longbridge.com/en/quote/688358.CN.md)

## Related News & Research

- [Western Digital CEO says AI data beats compute as long-term bet after 55% revenue jump](https://longbridge.com/en/news/302787456.md)
- [BE: Revenue rose 138% YoY as margins expanded and FY2026 guidance was raised again](https://longbridge.com/en/news/302787538.md)
- [GE Vernova Stock Is Taking a Hit – What's Driving the Selloff and What Wall Street Sees Next](https://longbridge.com/en/news/302747785.md)
- [Micron announces a new profit-sharing program](https://longbridge.com/en/news/302750416.md)
- [BofA Picks Its Favorite Between CoreWeave and Nebius](https://longbridge.com/en/news/302765116.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**